Induction of remission

The first stage of treatment, aimed at calming a flare and getting Crohn's under control.

Also called: inducing remission, getting into remission, calming a flare

Related words maintenance of remission remission induction

Topics Medicines Flare-ups

Questions people ask

What do 'flare-up' and 'remission' mean?

Crohn's usually comes and goes. Crohn's & Colitis UK describes remission as a time when Crohn's is well controlled, you feel better and tests show less inflammation, although some symptoms like tiredness may linger. A flare-up (also called a relapse or active disease) is when symptoms return and tests show the gut is inflamed. The NHS says a flare can last from a few days to several months.

Sources

Why are steroids only used for a short time?

Steroids such as prednisolone work well for calming a flare, but they cause side effects that become more likely the longer you take them. Crohn's & Colitis UK lists effects such as mood changes, sleep problems, skin changes and stomach problems. Cochrane reviews show steroids help bring Crohn's into remission, but budesonide does not keep it in remission long term. The 2025 BSG guideline warns against long or repeated steroid courses.

Sources

What does 'treat to target' mean?

It means your team agrees goals in advance and adjusts treatment until you reach them, rather than waiting for symptoms. The STRIDE-II expert agreement says early goals are feeling better and getting blood and poo inflammation tests back to normal; longer-term goals are a healed bowel lining, no disability, good quality of life and normal growth in children. The CALM trial found that stepping up treatment when tests showed inflammation, not just when symptoms flared, led to more bowel healing.

Sources

What is the CDAI, and how is it different from the HBI?

The Crohn's Disease Activity Index (CDAI) is an older, longer score. It needs a 7-day symptom diary, your weight and a blood test result, so it takes more effort to work out. A CDAI under 150 is taken as a marker of remission and over 450 as a marker of severe Crohn's. The Harvey-Bradshaw Index is a simpler score based on just the previous day's symptoms and does not need a blood test.

Sources

Why am I so tired all the time with Crohn's?

Fatigue is one of the commonest Crohn's symptoms. Crohn's & Colitis UK says it affects around 7 in 10 people during a flare and around 4 in 10 in remission, and has many possible causes. Anaemia from blood loss or poor absorption is one of them, so a blood test is worth asking about. A Cochrane review found only weak evidence so far for specific fatigue treatments.

Sources

Where to read more

Crohn's disease: management (NG129)

NICE Guideline May 2019 For professionals

NICE's guideline for the NHS in England on managing Crohn's in children, young people and adults. It covers giving people information and support, treatment to bring Crohn's under control and keep it there, surgery, keeping remission after surgery, checking bone health, and pregnancy. It is about care after diagnosis rather than how Crohn's is diagnosed.

Topics About Crohn's disease Medicines Surgery Monitoring Pregnancy and fertility Children and young people Steroids Immunosuppressants

Jargon explained remission inducing remission maintaining remission osteopenia NICE guideline induce remission maintain remission glucocorticosteroid thiopurine TPMT resection stricture

Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

The Lancet Study May 2022 Patients and professionals

Two trials testing risankizumab (Skyrizi) drips to bring active Crohn's under control, including in people for whom other biologics had failed. Risankizumab led to more remissions, and more improvement seen on camera tests of the bowel, at 12 weeks than placebo, and was generally well tolerated.

Topics Biologics and newer medicines

Jargon explained induction phase 3 trial endoscopic response

Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease

Cochrane Systematic review May 2025 Patients and professionals

Updated Cochrane review of ustekinumab (Stelara) and related drugs for active Crohn's. It found ustekinumab helps bring on remission by eight weeks and probably does not cause more serious side effects than placebo. There was not enough data to choose the best dose for children, and comparisons with other biologics are very uncertain.

Topics Biologics and newer medicines

Jargon explained IL-12/23 induction certainty of evidence

Budesonide for induction of remission in Crohn's disease

Cochrane Systematic review Jun 2015 Patients and professionals

Budesonide, a steroid that acts mainly in the gut, works better than placebo for bringing on remission. It is a bit less effective than standard steroids such as prednisolone, especially for severe or widespread colon disease, but causes fewer side effects and less suppression of the body's own steroid production.

Topics Steroids Research

Jargon explained budesonide corticosteroid adrenal suppression conventional steroids

Enteral nutritional therapy for induction of remission in Crohn's disease

Cochrane Systematic review Apr 2018 Patients and professionals

Compares liquid-only feeding (EN) with steroids for settling a Crohn's flare. Very low-quality evidence suggests steroids may work better in adults, while liquid feeds may work better in children. The type of formula did not seem to matter. The reviewers suggest EN for children, and for adults who can manage it or need to avoid steroids.

Topics Diet and nutrition Steroids Children and young people Research

Jargon explained enteral nutrition polymeric formula elemental diet nasogastric tube elemental feed polymeric feed

Diets for inducing and maintaining remission in inflammatory bowel disease (IBD)

Cochrane Systematic review Feb 2019 Patients and professionals

A Cochrane review of 18 trials that tested cutting down or cutting out foods thought to provoke IBD symptoms. The authors found the evidence too weak to say whether any of these diets help bring on or keep remission, and called for better trials. This summary dates from 2019.

Topics Diet and nutrition Research

Jargon explained remission exclusion diet randomised controlled trial

Aminosalicylates for induction of remission or response in Crohn's disease

Cochrane Systematic review Jul 2016 Patients and professionals

Mesalazine-type drugs (aminosalicylates) are widely used for ulcerative colitis, but this review found little evidence that they work for active Crohn's. Low and high doses of mesalazine were not clearly better than placebo. Some trials comparing high-dose mesalazine with budesonide gave mixed results.

Topics Medicines

Jargon explained aminosalicylate 5-ASA mesalazine

Search everything for "induction of remission"